Hims & Hers Health stock tumbles nearly 13% as bearish technical momentum and selling pressure dominate

Hims & Hers Health stock tumbles nearly 13% as bearish technical momentum and selling pressure dominate
Hims & hers health slides 12.89% today

Hims & Hers Health Inc (HIMS) tumbled 12.89% amid extended selling pressure and pronounced intraday volatility, as technical momentum and bearish trend signals dominated the session. The move is reinforced by the stock’s position below its 20-day, 50-day, and 200-day moving averages, which confirms sellers are in control across all major timeframes.

HIMS price prediction
24H -3.08%
$29.28
48H -1.19%
$29.85
7D 1.06%
$30.53
1M -5.89%
$28.43
3M -18.54%
$24.61
6M -26.42%
$22.23
12M -45.55%
$16.45
Current price: $ 30.21 2.12 7.55%
Real-time Data 14:55
Daily range 28.25 Arrow from to Icon 29.79
Weekly range 27.98 Arrow from to Icon 35.85
Loading...

Highlights

  • Hims & Hers Health is trading below major moving averages, confirming bearish control across all time frames.
  • Momentum signals are mixed, with oversold oscillators contrasting with intraday buying pressure as volatility spikes to 17.98%.
  • Expected five-day trading range is $24.02 to $31.04, with a 57% chance of sideways-to-upward consolidation near current prices.

Anton Kharitonov, expert at Traders Union, sees Hims & Hers Health Inc under sustained technical pressure. The persistent breakdown below critical moving averages points to an extended bearish structure. He notes that momentum signals are conflicted but the dominance of sellers is unmistakable. Kharitonov finds the lack of positive news and consistently high volatility troubling for near-term recovery. "With sellers in clear control and no fundamental catalyst, I remain skeptical of any sustained upside in the short term."

Viktoras Karapetjanc, expert at Traders Union, views the present volatility as an opportunity for strategic positioning. He believes the oversold readings and strong intraday buyer activity hint at the groundwork for reversal setups. Karapetjanc sees potential for upside, especially if price reclaims $31.04, as bullish momentum may quickly reassert itself. "While short-term noise remains, the market offers attractive setups for those able to act on improving momentum and renewed demand."

Mixed momentum signals as prices consolidate near oversold levels

Hims & Hers Health is trading below its 20-day, 50-day, and 200-day moving averages ($34.63, $30.24, and $31.19, respectively), reflecting continued bearish momentum in short-, medium-, and long-term trends. Immediate support is found at $24.02, with resistance noted near the current session low at $29.09. The alignment of the moving averages supports a bearish long-term technical outlook. Momentum indicators are mixed: the MACD shows a strong buy forecast, but the ADX remains neutral, RSI sits at 48.98 with a mild sell reading, and both the Stochastic RSI (15.02) and CCI also signal oversold or sell conditions. Bull/Bear Power (BBP) is strongly positive at 2.13, highlighting intraday buyer activity, yet flagged as overbought amid high volatility of 17.98%. Overall, momentum signals are diverging, with oscillators oversold but buyers showing pockets of strength intraday.

Earlier, analysts noted that Hims & Hers Health faced persistent selling pressure and maintained a broadly bearish technical outlook. The current session reinforces this bearish stance with continued high volatility, making any sustained move above $31.04 or below $24.02 a critical signal for traders watching for the stock’s next direction.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.